πŸ‡ΊπŸ‡Έ FDA
Patent

US 11834512

Inhibiting anti-ENPP1 antibodies

granted A61PA61P9/10

Quick answer

US patent 11834512 (Inhibiting anti-ENPP1 antibodies) held by The Regents of the University of California expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P9/10